Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
carcinogenicity
Type of information:
(Q)SAR
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Justification for type of information:
QSAR prediction: migrated from IUCLID 5.6

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Report date:
2015

Materials and methods

Principles of method if other than guideline:
Carcinogenicity on mouse and rat (male, female) was estimated by using two predictors: Leadscope Model Applier and ACD/Percepta.
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
2-chloro-4-(1H-pyrazol-3-yl)benzonitrile
EC Number:
941-761-7
Cas Number:
1297537-37-1
Molecular formula:
C10H6N3Cl
IUPAC Name:
2-chloro-4-(1H-pyrazol-3-yl)benzonitrile

Test animals

Species:
other: rat and mouse
Sex:
male/female

Results and discussion

Any other information on results incl. tables

Name

Model

ACD/Percepta

Leadscope

Consensus prediction

2-chloro-4-(1H-pyrazol-5-yl)benzonitrile

Rat male

NOT IN THE DOMAIN

NEGATIVE

(borderline reliable)

NEGATIVE

(borderline reliable)

Rat female

NOT IN THE DOMAIN

POSITIVE

(borderline reliable)

POSITIVE

(borderline reliable)

Name

Model

ACD/Percepta

Leadscope

Consensus prediction

2-chloro-4-(1H-pyrazol-5-yl)benzonitrile

Mouse male

NOT IN THE DOMAIN

NEGATIVE

(borderline reliable)

NEGATIVE

(borderline reliable)

Mouse female

NOT IN THE DOMAIN

NEGATIVE

(borderline reliable)

NEGATIVE

(borderline reliable)

 

ACD/Percepta did not provide any prediction since the 2-chloro-4-(1H-pyrazol-5-yl)benzonitrile compound resulted out of the applicability domain of the two models.

Leadscope Model Applier

Leadscope prediction for carcinogenicity on rat:

Name

Model

Prediction call

Positive

Prediction probability

Prediction reliability parameters

Model Features

Count

30% Sim. Training Neighbors Count

Reliability

assessment

2-chloro-4-(1H-pyrazol-5-yl)benzonitrile

Carc Rat Male

NEGATIVE

0.40

5

5

BORDERLINE RELIABLE

Car Rat Female

POSITIVE

0.70

7

5

BORDERLINE RELIABLE

Leadscope FDA Model Applier prediction forcarcinogenicity on rat male and femaleresulted to be NEGATIVE and POSITIVE, respectively since the positive prediction probability was equal to 0.40 (male) and 0.70 (female). Since at least 5 features were found, it was concluded that 2-chloro-4-(1H-pyrazol-5-yl)benzonitrile is well represented by the models.The robustness of the prediction was further evaluated by examining compounds similar to the 2-chloro-4-(1H-pyrazol-5-yl)benzonitrile from the training set.While this information does not take part to the prediction, it provides the complementary means to see how similar compounds were predicted and what the experimental values of similar compounds are. Five structures from the training set ofCar Rat Malemodel and 7 structures from the training set ofCar Rat Femalemodel were identified as analogues to 2-chloro-4-(1H-pyrazol-5-yl)benzonitrile (similarity > 30%), but none of them withsimilarity greater than 0.5. Based on that, Leadscope predictions wereassessed as borderline reliable.

Leadscope prediction for carcinogenicity on mouse:

Name

Model

Prediction call

Positive

Prediction probability

Prediction reliability parameters

Model Features

Count

30% Sim. Training Neighbors Count

Reliability

assessment

2-chloro-4-(1H-pyrazol-5-yl)benzonitrile

Carc Mouse Male

NEGATIVE

0.33

5

4

BORDERLINE

RELIABLE

Carc Mouse Female

NEGATIVE

0.44

5

4

BORDERLINE

RELIABLE

Leadscope FDA Model Applier prediction forcarcinogenicity on mouse (both males and females)resulted to be NEGATIVE, since the positive prediction probability was equal to 0.33 (male) and 0.44 (female). Since at least 5 features were found, it was concluded that 2-chloro-4-(1H-pyrazol-5-yl)benzonitrile is well represented by the models.Additionally, the majority of/all the identified features are mainly represented in negative training compounds.The robustness of the prediction was further evaluated by examining compounds similar to the 2-chloro-4-(1H-pyrazol-5-yl)benzonitrile from the training set.While this information does not take part to the prediction, it provides the complementary means to see how similar compounds were predicted and what the experimental values of similar compounds are. Four structures from the training set ofCar Mouse Malemodel and 5 structures from the training set ofCar Mouse Femalemodel were identified as analogues to 2-chloro-4-(1H-pyrazol-5-yl)benzonitrile (similarity > 30%), but none of them with similarity greater than 0.5.Based on that, Leadscopepredictions were assessed as borderline reliable.

Applicant's summary and conclusion

Conclusions:
Since ACD/Percepta did not provide any prediction, based on Leadscope predictions of carcinogenicity on rat and mouse male and female and according to a precautionary approach, it was concluded that the target 2-chloro-4-(1H-pyrazol-5-yl)benzonitrile is predicted as SUSPECT POSITIVE on rat and NEGATIVE for mouse, although the prediction was assessed as borderline reliable.